Phase III Trials

mRNA COVID Vaccines Linked to Longer Survival With Checkpoint Immunotherapy, Peer‑Reviewed Study Finds

Investigators will test causation in randomized multi‑center trials following preclinical evidence of an immune‑priming effect.